December 22, 2014 6:28 PM ET

Healthcare Equipment and Supplies

Company Overview of Biomet 3i LLC

Company Overview

Biomet 3i LLC develops implants for dental health care providers. It offers implant systems, overdenture implant systems, healing abutments, and cover screws; scanners, bone grafts, synthetic bone graft substitutes, barrier membranes, and regenerative instrumentation; and cement-retained abutments, screw-retained abutments, abutment healing caps, overdenture abutments, overdenture components, and overdenture drivers and tips. The company also provides implant impression copings, abutment impression copings, temporary cylinders and provisional abutments, screws, and analogs; surgical kits, bone taps, drills, bone profilers, osteotomes, powered surgical drill units and accessories, torque driv...

4555 Riverside Drive

Palm Beach Gardens, FL 33410-4200

United States

Founded in 1987

Phone:

561-776-6700

Fax:

561-776-1272

Key Executives for Biomet 3i LLC

Principal Executive Officer and President
Age: 56
Chief Financial Officer
Chief Procurement Officer
Principal Accounting Officer
Secretary and Manager
Age: 55
Compensation as of Fiscal Year 2014.

Biomet 3i LLC Key Developments

Biomet 31 LLC Wins $27,774,800 Federal Contract

Biomet 31 LLC, Palm Beach Gardens, Florida, was awarded a $27,774,800 federal contract by the Defense Logistics Agency Troop Support, Philadelphia, for medical items and accessories.

BIOMET 3i Announces Launching of its New 3i T3 Implant

BIOMET 3i announced that it is launching its new 3i T3 Implant. The 3i T3 Implant is a contemporary hybrid implant with a new multi-surface topography designed to deliver aesthetic results through tissue preservation. Coarse Micron Topography: A resorbable media blasting process using calcium phosphate particles provides 10 micron features, which facilitate blood clot retention along the threaded body of the implant1,2. Fine Micron Topography: A dual acid-etching process provides a 1-3 micron peak-to-peak surface (OSSEOTITE®) that supports platelet activation3,4. This surface overlays the coarse micron topography and is designed to mitigate the risk of peri-implantitis at the coronal aspect of the implant5. Sub-Micron Topography: The option exists for a more complex topography with the discrete crystalline deposition of calcium phosphate nanoparticles. This surface treatment has demonstrated increased integration throughout the early healing process, helping to facilitate Bone Bonding®*6. Integrated Platform Switching: BIOMET 3i Implants with integrated platform switching (3i T3 and PREVAIL® Implants) have smaller restorative platforms relative to the total implant platform. This medializes the Implant-Abutment junction inward, helping to maintain bone levels. Studies show that BIOMET 3i Implants with integrated platform switching demonstrated crestal bone loss as low as 0.37mm7. Certain® Internal Connection and the Gold-Tite® Screw: The Certain Internal Connection in conjunction with the Gold-Tite Screw is designed to reduce microleakage through its exacting interface tolerances and maximized clamping forces8. The Gold-Tite Screw design increases the clamping force by 113% versus non-coated screws, maximizing abutment stability. The Gold-Tite Surface lubricates and compresses to provide a tighter fit between implant components9.

Innocoll, Inc. Enters into an Exclusive License and Distribution Agreement with Biomet 3i

Innocoll, Inc. announced it has entered into an exclusive license and distribution agreement with Biomet 3i for its range of CollaCare Dental products. This agreement covers all global territories outside of China and ASEAN, which have been previously partnered. The CollaCare products were developed using Innocoll's proprietary collagen based technologies. The products are comprised of a lyophilized matrix of purified type I collagen available in a variety of easy-to-apply formats including sponge, tape, cone, and powder. The products are indicated for topical hemostasis and/or the management to clean oral wounds such as dental and periodontal surgical wounds, extraction sites, traumatic oral wounds, denture sores, oral ulcers, and burns. Because the products are composed of native fibrillar collagen, Collacare Dental has intrinsic haemostatic properties such that topical administration directly over the wound effectively controls bleeding, usually within approximately three minutes. The highly porous structure also enables absorption of fluids and upon hydration the dressings are conformable to the shape of the wound. Collacare Dental may also serve as temporary wound dressings during prolonged dental procedures. CollaCare dental products are currently approved for sale in the United States and Europe.

Similar Private Companies By Industry

Company Name Region
Systagenix Wound Management (US), Inc. United States
RF Surgical Systems, Inc. United States
Trinity Sterile, Inc. United States
Blue Bell Bio-Medical, Inc. United States
Vicon Fiber Optics Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Biomet 3i LLC, please visit www.biomet3i.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.